2010
DOI: 10.1073/pnas.0908359107
|View full text |Cite
|
Sign up to set email alerts
|

A mutation in the first intracellular loop of CACNA1A prevents P/Q channel modulation by SNARE proteins and lowers exocytosis

Abstract: Familial hemiplegic migraine (FHM)-causing mutations in the gene encoding the P/Q Ca 2+ channel α 1A subunit (CACNA1A) locate to the pore and voltage sensor regions and normally involve gainof-channel function. We now report on a mutation identified in the first intracellular loop of CACNA1A (α 1A(A454T) ) that does not cause FHM but is associated with the absence of sensorimotor symptoms in a migraine with aura pedigree. α 1A(A454T) channels showed weakened regulation of voltage-dependent steady-state inactiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
28
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
4
3

Relationship

3
4

Authors

Journals

citations
Cited by 22 publications
(30 citation statements)
references
References 37 publications
2
28
0
Order By: Relevance
“…Besides modulating T-type Ca 2ϩ channel gating, the physical association between Ca v 3.2 channel and SNARE proteins may contribute significantly to optimize Ca v 3.2-mediated exocytosis. Consistent with previous studies showing that Ca v 2.1, Ca v 2.2, or Ca v 3.1 channels can trigger voltage-dependent exocytosis when heterologously expressed in MPC-9/3L cells (6,31,48), we show that expression of Ca v 3.2 channel in these cells induced robust voltage-dependent exocytosis that was drastically reduced when SNARE proteins were competitively uncoupled from the channel by co-expression of the carboxylterminal domain of the Ca v 3.2 subunit. This result is consistent with previous studies showing that disruption of N-and P/Qtype Ca 2ϩ channel-SNARE interaction by a peptide containing the synprint site prevents neurotransmitter release (12,13).…”
Section: Discussionsupporting
confidence: 78%
See 1 more Smart Citation
“…Besides modulating T-type Ca 2ϩ channel gating, the physical association between Ca v 3.2 channel and SNARE proteins may contribute significantly to optimize Ca v 3.2-mediated exocytosis. Consistent with previous studies showing that Ca v 2.1, Ca v 2.2, or Ca v 3.1 channels can trigger voltage-dependent exocytosis when heterologously expressed in MPC-9/3L cells (6,31,48), we show that expression of Ca v 3.2 channel in these cells induced robust voltage-dependent exocytosis that was drastically reduced when SNARE proteins were competitively uncoupled from the channel by co-expression of the carboxylterminal domain of the Ca v 3.2 subunit. This result is consistent with previous studies showing that disruption of N-and P/Qtype Ca 2ϩ channel-SNARE interaction by a peptide containing the synprint site prevents neurotransmitter release (12,13).…”
Section: Discussionsupporting
confidence: 78%
“…Total charge transferred during each pulse was evaluated by integrating the area below gating current trace at the beginning (Q on ) and after the end of each depolarizing pulse (Q off ). For capacitance measurements, MPC 9/3L-AH cells were transfected using Lipofectamine Plus (Invitrogen), as previously reported (6,31 and had a resistance of 2-4 M⍀. Capacitance measurements were performed using an EPC-10 patch-clamp amplifier using the "sine ϩ dc" software lock-in amplifier method implemented in PatchMaster software.…”
Section: Methodsmentioning
confidence: 99%
“…The whole-cell configuration of the patch-clamp technique was employed as previously describe to test for the functional expression of TRP channel activity (Fernandes et al, 2008) and voltage-gated calcium currents (Serra et al, 2010). Pipettes with a resistance of 2–3 MΩ were used.…”
Section: Methodsmentioning
confidence: 99%
“…Clinical variation is also seen within the HM phenotype, a condition in which CACNA1A may sometimes be implicated as a modifier gene rather than a disease‐causing gene (Serra et al. ). Typical attacks in HM are often associated with other aura symptoms: the clinical spectrum includes permanent cerebellar signs and, less frequently, various types of epileptic seizures, mental retardation, and coma.…”
Section: Introductionmentioning
confidence: 99%